General Information of the Compound
| Compound ID |
CP0911525
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(2-(3-Bromo-4-methoxyphenyl)ethyl)-(6R*)-N6-(4-pyrrolidino-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide, formate salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H40BrN3O5
|
||||||||||||||||||
| Molecular Weight |
590.559
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(CCNC(=O)[C@H]2[C@H](C(=O)NCCCCN3CCCC3)[C@H]3C=C[C@@H]2C32CC2)cc1Br.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H38BrN3O3.CH2O2/c1-35-23-9-6-19(18-22(23)29)10-14-31-27(34)25-21-8-7-20(28(21)11-12-28)24(25)26(33)30-13-2-3-15-32-16-4-5-17-32;2-1-3/h6-9,18,20-21,24-25H,2-5,10-17H2,1H3,(H,30,33)(H,31,34);1H,(H,2,3)/t20-,21+,24-,25-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PTGHRPIBWSQNOT-OIJWZCBCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2